Browser-side verification
Verify Buprenorphine
คุณไม่ต้องเชื่อ source.cuvetsmo.com — โค้ดด้านล่างทำงานในเครื่องของคุณ คำนวณ SHA-256 และ verify Ed25519 signature เทียบกับ public key ที่อาจารย์เซ็นต์รับเก็บไว้.
Signatures
0
Version
1
Status
pending
⏳ ยังไม่มี signature
Entry นี้ยังไม่ได้ลงนามโดย key ใดเลย — Phase 0 mirror snapshot ที่รอ Thai translation + faculty signoff. ดูสถานะการ review ที่ หน้า detail
Show the raw inputs (paranoid mode)
Drug JSON
This is exactly what your browser canonicalizes + SHA-256-hashes
{
"slug": "buprenorphine",
"nameEn": "Buprenorphine",
"nameTh": "บูพรีนอร์ฟีน",
"class": "Opioid analgesic — partial mu agonist (ceiling effect)",
"mechanism": "opioid partial mu agonist ออกฤทธิ์แรงกว่า morphine ~25–50 เท่า แต่มี ceiling effect (เพิ่มขนาดไม่เพิ่มฤทธิ์ระงับปวด); ออกฤทธิ์นาน; ในแมวดูดซึมดีทาง oral transmucosal (OTM)",
"brandNamesTh": [
"Vetergesic",
"Simbadol",
"Buprenex"
],
"indications": [
{
"text": "ระงับปวดเบาถึงปานกลาง; ในแมวนิยมหยอดใต้ลิน/กระพุ้งแก้ม (OTM) เพราะดูดซึมดีและให้ที่บ้านสะดวก",
"cites": [
"merck-pain-mgmt",
"dvm360-analgesia"
]
}
],
"contraindications": [
{
"text": "ไม่เหมาะกับปวดรุนแรง (ceiling effect); naloxone แก้ฤทธิ์ได้ยากกว่าเพราะจับ receptor แน่น",
"cites": [
"merck-pain-mgmt"
]
}
],
"sideEffects": [
{
"text": "กดการหายใจน้อยกว่า pure agonist, ง่วงซึม, คลื่นไส้; ออกฤทธิ์นานทำให้ reversal ยาก",
"cites": [
"merck-pain-mgmt"
]
}
],
"dosages": [
{
"species": "canine",
"indication": "Mild–moderate pain",
"route": "IM",
"dose": "0.01–0.02 mg/kg IV/IM ทุก 6–8 ชั่วโมง",
"cites": [
"merck-pain-mgmt",
"dvm360-analgesia"
]
},
{
"species": "feline",
"indication": "Mild–moderate pain",
"route": "IM",
"dose": "0.01–0.02 mg/kg IV/IM หรือ OTM (กระพุ้งแก้ม) ทุก 6–8 ชั่วโมง",
"cites": [
"merck-pain-mgmt",
"dvm360-analgesia"
]
}
],
"citations": [
{
"id": "merck-pain-mgmt",
"type": "textbook",
"title": "Pain Management in Small Animals — MSD/Merck Veterinary Manual",
"year": 2025,
"url": "https://www.merckvetmanual.com/musculoskeletal-system/lameness-in-small-animals/pain-management-in-small-animals-with-lameness",
"note": "Merck pain-management reference — opioid dosing + mu/kappa pharmacology. Copyrighted, cited not mirrored.",
"cid": null
},
{
"id": "dvm360-analgesia",
"type": "guideline",
"title": "Analgesic drugs and sedatives (Proceedings) — dvm360",
"year": 2024,
"url": "https://www.dvm360.com/view/analgesic-drugs-and-sedatives-proceedings",
"note": "Veterinary CE proceedings — opioid dose ranges for dogs and cats. Secondary clinical reference.",
"cid": null
},
{
"id": "dailymed-buprenorphine",
"type": "regulatory-database",
"title": "Buprenorphine — NLM DailyMed (FDA Structured Product Labeling)",
"year": 2025,
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=buprenorphine",
"note": "Cross-checked source: FDA-approved labeling. Search by name returns relevant product labelings.",
"cid": "12fc967569209747c130745cbf0ecc55cabb98fdd67c1d18231e65e49e97683e"
},
{
"id": "atc-N02AE01",
"type": "guideline",
"title": "ATC N02AE01 — Buprenorphine",
"year": 2025,
"url": "https://www.whocc.no/atc_ddd_index/?code=N02AE01&showdescription=no",
"note": "Cross-checked source: WHO Collaborating Centre ATC/DDD index. Authoritative drug classification.",
"cid": "533fdbe353295669b719902dc18da48eef8329c4c88be983c671e3e0f8a202db"
},
{
"id": "pubchem-buprenorphine",
"type": "monograph",
"title": "Buprenorphine — PubChem search",
"year": 2025,
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Buprenorphine",
"note": "Cross-checked source: chemical structure, identifiers, pharmacology summary. Faculty review fills exact CID.",
"cid": "34986eabc0827928cb1d9aefa55c84663056a65a5ee90bbb2b9b66664d260d01"
},
{
"id": "wsava-pain-2022",
"type": "guideline",
"title": "WSAVA Global Pain Council — Guidelines for Recognition, Assessment and Treatment of Pain",
"year": 2022,
"url": "https://wsava.org/global-guidelines/global-pain-council-guidelines/",
"note": "Cross-checked source: WSAVA global vet community standard for pain management.",
"cid": "4f3dfbc8262369e4ed25263fc5fd4051710cda271692dda3c34ef6bcf96b22aa"
}
],
"mirroredFrom": [
{
"id": "dailymed",
"name": "NLM DailyMed",
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=buprenorphine",
"asOfDate": "2026-05-27",
"license": "U.S. Government work — public domain. Attribution recommended."
},
{
"id": "atc",
"name": "WHO ATC Classification",
"url": "https://www.whocc.no/atc_ddd_index/?code=N02AE01&showdescription=no",
"asOfDate": "2026-05-27",
"license": "WHO publication, free for use with attribution"
},
{
"id": "pubchem",
"name": "PubChem (NIH/NLM)",
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Buprenorphine",
"asOfDate": "2026-05-27",
"license": "NIH/NLM public domain"
},
{
"id": "wsava-pain",
"name": "WSAVA Global Pain Council guidelines",
"url": "https://wsava.org/global-guidelines/global-pain-council-guidelines/",
"asOfDate": "2026-05-27",
"license": "Free for educational use with attribution"
}
],
"mirrorCIDs": [
{
"sourceId": "dailymed",
"cid": "12fc967569209747c130745cbf0ecc55cabb98fdd67c1d18231e65e49e97683e",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "atc",
"cid": "533fdbe353295669b719902dc18da48eef8329c4c88be983c671e3e0f8a202db",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "pubchem",
"cid": "34986eabc0827928cb1d9aefa55c84663056a65a5ee90bbb2b9b66664d260d01",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "wsava-pain",
"cid": "4f3dfbc8262369e4ed25263fc5fd4051710cda271692dda3c34ef6bcf96b22aa",
"capturedAt": "2026-05-27",
"status": "stub"
}
],
"codes": {
"atc": {
"code": "N02AE01",
"name": "Buprenorphine",
"level": 5
},
"rxnorm": {
"cui": "1819",
"name": "Buprenorphine"
}
},
"drafting": {
"aiAssisted": false,
"aiModel": null,
"aiPromptHash": null,
"humanReviewer": "palmzamak2547",
"humanReviewedAt": "2026-05-27",
"humanEditsRatio": null
},
"signatures": [],
"reviewedBy": null,
"lastUpdated": "2026-05-27",
"version": 1,
"changelog": [
{
"version": 0,
"date": "2026-05-27",
"summary": "Seed entry — cross-checked from 4 authoritative sources (NLM DailyMed, WHO ATC Classification, PubChem (NIH/NLM), WSAVA Global Pain Council guidelines). ATC N02AE01 + RxNorm 1819. Thai translation + faculty review pending."
},
{
"version": 1,
"date": "2026-05-27",
"summary": "Clinical content compiled from cited sources — buprenorphine 0.01–0.02 mg/kg + feline OTM route + ceiling effect verified against Merck pain-management + dvm360. Every statement cited. Reviewed by palmzamak2547. Pending faculty canonical signature."
}
]
}Public keys used
[]